Literature DB >> 5652112

Concept of a volume of distribution and possible errors in evaluation of this parameter.

S Riegelman, J Loo, M Rowland.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 5652112     DOI： 10.1002/jps.2600570125

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  49 in total

1.  Assuming peripheral elimination: its impact on the estimation of pharmacokinetic parameters of muscle relaxants.

Authors:  J Laurin; F Nekka; F Donati; F Varin
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

2.  The role of the kidney in the elimination of cephapirin in man.

Authors:  B E Cabana; D R Van Harken; G H Hottendorf; J T Doluisio; W O Griffen; D W Bourne; L W Dittert
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

3.  Pharmacokinetics of theophylline in relation to increased pain sensitivity in the rat.

Authors:  L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

4.  Pharmacokinetics in man of the N-acetylated metabolite of procainamide.

Authors:  J M Strong; J S Dutcher; W K Lee; A J Atkinson
Journal:  J Pharmacokinet Biopharm       Date:  1975-08

5.  Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.

Authors:  W R Gillespie
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

6.  A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variations in drug elimination.

Authors:  D P Vaughan; A Trainor
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

7.  Time-dependent effects of theophylline on myocardial reactive hyperaemias in the anaesthetized dog.

Authors:  J M Gidday; J W Esther; S W Ely; R Rubio; R M Berne
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

8.  Absorption and disposition of a new antiarrhythmic agent bidisomide in man.

Authors:  C S Cook; G B Ames; M E Smith; K G Kowalski; A Karim
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

9.  The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.

Authors:  D S Reeves; D W Bullock; M J Bywater; H A Holt; L O White; D P Thornhill
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

10.  Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.

Authors:  D R Bevan; J D D'Souza; J M Rouse; J Caldwell; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.